The convergence of expression and structural data reframes pleiotrophin–ITGB3 signaling as a central axis of immune–neurovascular integration, underscoring its potential to reshape current strategies for diagnosis and treatment in multiple sclerosis. Here, PTN is linked to multiple sclerosis.